An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy
Clinical trial NCT05255861 · UNKNOWN
Trial details
- NCT number
- NCT05255861
- Sponsor
- Xin Wu
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.